Peroxisome proliferator-activated receptor-γ haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis

Journal of Clinical Investigation

Volumn 108, Issue 11, 2001, Pages 1667-1675

  Setoguchi, K ^a   Misaki, Y ^a   Terauchi, Y ^a   Yamauchi, T ^a   Kawahata, K ^a   Kadowaki, T ^a   Yamamoto, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0035210586     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13202     Document Type: Article

References (45)

1. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
2. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
3. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
4. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
5. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
6. Roles of PPARs in health and disease
7. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
8. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
9. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses
10. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation in naive mouse T cells induces cell death
11. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT
12. PPAR-gamma-mediated regulation of normal and malignant B lineage cells
13. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells
14. An antidiabetic rhiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
15. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma
16. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway
17. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
18. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
19. Pathology of rheumatoid arthritis and associated disorders
20. Pathogenesis of rheumatoid arthritis
21. T cell clonality in the rheumatic diseases
22. Rheumatoid factor and immune networks
23. 15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
24. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
25. Insights into insulin resistance and type 2 diabetes from knockout mouse models
26. PPAR gamma is required for placental, cardiac, and adipose tissue development
27. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
28. Altered expression level of a systemic nuclear autoantigen determines the fate of immune response to self
29. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen
30. CD3- and CD28-dependent induction of PDE7 required for T cell activation
31. FcR gamma chain deletion results in pleiotrophic effector cell defects
32. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
33. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation
34. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation
35. Phosphorylation meets ubiquitination: The control of NF-kappa B activity
36. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes
37. Toll-like receptors in the induction of the innate immune response
38. Toll-like receptor-mediated NF-κB activation: A phylogenetically conserved paradigm in innate immunity
39. Initiation and processing of signals from the B cell antigen receptor
40. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B
41. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators
42. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes
43. Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity
44. B cells
45. Systemic autoimmune disease arises from polyclonal B cell activation